ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

NCI Reorganization Task Forces Near Decisions On New Division’s Makeup; Terry May Be Canidate

May 25, 1979

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012

Part One Of A Two-Part Interview With NCI Director Harold Varmus

July 22, 2011

Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study

March 28, 2014